Analysts expect that Alteryx, Inc. (NYSE:AYX) will announce $122.37 million in sales for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Alteryx’s earnings. The highest sales estimate is $123.50 million and the lowest is $121.00 million. Alteryx reported sales of $129.72 million in the same quarter last year, which would suggest a negative year-over-year growth rate of 5.7%. The company is expected to report its next earnings results on Thursday, November 4th.
According to Zacks, analysts expect that Alteryx will report full-year sales of $525.61 million for the current fiscal year, with estimates ranging from $522.46 million to $527.72 million. For the next year, analysts anticipate that the company will post sales of $613.83 million, with estimates ranging from $564.40 million to $637.80 million. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that cover Alteryx.
Alteryx (NYSE:AYX) last released its quarterly earnings data on Monday, August 2nd. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.25) by $0.17. Alteryx had a negative net margin of 10.91% and a negative return on equity of 6.16%. The business had revenue of $120.07 million for the quarter, compared to analyst estimates of $112.71 million.
NYSE:AYX traded up $1.33 on Wednesday, reaching $74.80. The stock had a trading volume of 1,049,433 shares, compared to its average volume of 1,194,525. The company has a market cap of $5.03 billion, a price-to-earnings ratio of -84.52 and a beta of 0.71. The company has a debt-to-equity ratio of 1.56, a current ratio of 2.99 and a quick ratio of 2.99. The firm’s fifty day moving average is $72.53 and its two-hundred day moving average is $78.25. Alteryx has a 12-month low of $66.66 and a 12-month high of $145.88.
In related news, Director Dean Stoecker sold 10,000 shares of the firm’s stock in a transaction on Wednesday, July 21st. The stock was sold at an average price of $79.96, for a total transaction of $799,600.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders have sold 57,500 shares of company stock valued at $4,151,150. Company insiders own 12.50% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of the company. Bessemer Group Inc. boosted its position in shares of Alteryx by 231.5% in the 2nd quarter. Bessemer Group Inc. now owns 358 shares of the company’s stock valued at $31,000 after purchasing an additional 250 shares during the period. SRS Capital Advisors Inc. acquired a new stake in shares of Alteryx during the 2nd quarter valued at about $34,000. Asset Management One Co. Ltd. acquired a new stake in shares of Alteryx during the 2nd quarter valued at about $34,000. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Alteryx by 1,009.5% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 699 shares of the company’s stock valued at $58,000 after buying an additional 636 shares during the last quarter. Finally, Canada Pension Plan Investment Board raised its stake in shares of Alteryx by 178.6% in the 1st quarter. Canada Pension Plan Investment Board now owns 769 shares of the company’s stock valued at $64,000 after acquiring an additional 493 shares in the last quarter. 66.03% of the stock is currently owned by institutional investors.
Alteryx Company Profile
Alteryx, Inc engages in the provision of self-service data analytics software. Its subscription-based platform allows organizations to prepare, blend, and analyze data from a multitude of sources and benefit from data-driven decisions. The company was founded by Dean A. Stoecker, Olivia Duane-Adams, and Edward P.
See Also: Stock Symbols and CUSIP Explained
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.